Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BARHL1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
mRNA | DLL1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
mRNA | RMI1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
mRNA | TUBB2B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
mRNA | AGBL1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
mRNA | GOLGA8N | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
mRNA | JAM3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
mRNA | PCMTD2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
mRNA | USO1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
mRNA | FRMPD2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |